| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2018/02/15 | 07 : 54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2018/02/15 | 04 : 53 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/22 | 06 : 26 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/21 | 20 : 04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/15 | 02 : 08 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 20 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 20 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 20 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 07 : 00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 06 : 54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 06 : 44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 06 : 40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/14 | 06 : 33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 05 : 20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00 : 26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00 : 26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00 : 23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00 : 22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00 : 19 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00 : 18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00 : 16 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 2017/12/12 | 00 : 13 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |